{"entity":{"id":"lim-soon-thye","kind":"person","name":"Lim Soon Thye","aka":[],"tldr":"Lymphoma specialist and Chief Executive Officer of the National Cancer Centre Singapore, the country's largest public cancer centre.","summary":"Lim Soon Thye is Chief Executive Officer of the National Cancer Centre Singapore (NCCS), part of the SingHealth cluster. A medical oncologist specialising in lymphoma, he has led research on T-cell and NK/T-cell lymphomas prevalent in Asian populations and co-founded regional lymphoma study groups. As CEO he oversees NCCS's clinical services, research divisions and education programmes.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.nccs.com.sg/about-nccs/leadership.html"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lim+ST%5BAuthor%5D+Singapore+lymphoma"}],"tags":["leadership","clinician-scientist","lymphoma"],"related":[],"cancers":["peripheral-t-cell-lymphoma","dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["nccs"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["asco-educational-book","journal-of-hematology-and-oncology"],"dependsOn":[],"notes":[],"role":"Chief Executive Officer","institutionId":"nccs","specialisms":["Lymphoma","Medical oncology","Health system leadership"],"profiles":[{"label":"Institution profile","url":"https://www.nccs.com.sg/about-nccs/leadership.html"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lim+ST%5BAuthor%5D+Singapore+lymphoma"}],"papers":[{"title":"Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial","journal":"Blood","year":2018,"doi":"10.1182/blood-2017-09-804641"},{"title":"Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group","journal":"Journal of Hematology & Oncology","year":2020,"doi":"10.1186/s13045-020-00855-9"},{"title":"Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder","journal":"American Society of Clinical Oncology Educational Book","year":2016,"doi":"10.1200/edbk_159030"}]},"route":"/people/lim-soon-thye/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"peripheral-t-cell-lymphoma","kind":"cancer","name":"Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma)","route":"/cancers/peripheral-t-cell-lymphoma/"}],"institution":[{"id":"nccs","kind":"institution","name":"National Cancer Centre Singapore","route":"/institutions/nccs/"}],"journal":[{"id":"asco-educational-book","kind":"journal","name":"American Society of Clinical Oncology educational book","route":"/journals/asco-educational-book/"},{"id":"journal-of-hematology-and-oncology","kind":"journal","name":"Journal of hematology & oncology","route":"/journals/journal-of-hematology-and-oncology/"}]}}